QOP
ANGO icon

Quinn Opportunity Partners’s AngioDynamics ANGO Stock Holding History

Quinn Opportunity Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114K Hold
10,000
– – 0.01% 342
2025
Q4 		$128K Hold
10,000
– – 0.01% 344
2025
Q3 		$112K Hold
10,000
– – 0.01% 301
2025
Q2 		$99.2K Hold
10,000
– – 0.01% 321
2025
Q1 		$93.9K Hold
10,000
– – 0.01% 369
2024
Q4 		$91.6K Buy
+10,000
New +$73.5K 0.01% 361

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Quinn Opportunity Partners's ANGO Position: Q1 2026 in Review

Quinn Opportunity Partners held its AngioDynamics (ANGO) position steady in Q1 2026 at 10,000 shares worth $114K. The position accounts for 0.01% of the portfolio, ranked #342.

Quinn Opportunity Partners first reported a position in ANGO in Q4 2024 and has held it in 6 quarters since. The position peaked at $128K in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Quinn Opportunity Partners held 10,000 shares of AngioDynamics worth $114K as of Q1 2026.
  • Quinn Opportunity Partners left its AngioDynamics share count unchanged in Q1 2026.
  • AngioDynamics made up 0.01% of Quinn Opportunity Partners's portfolio in Q1 2026, its #342 holding.
  • Quinn Opportunity Partners first reported a position in AngioDynamics in Q4 2024 and has held it in 6 quarters since.
  • Quinn Opportunity Partners's AngioDynamics position peaked at $128K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.